Azenta Inc (AZTA)

53.38 +0.82 (+1.56%) USD  |  NASDAQ  |  May 03, 16:00
53.38 0.00 (0.00%) After-Hours: 18:21
More

Azenta Research and Development Expense (Quarterly): 8.493M for Dec. 31, 2023

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 1996. Upgrade now.
Date Value
December 31, 2023 8.493M
September 30, 2023 8.932M
June 30, 2023 8.968M
March 31, 2023 8.52M
December 31, 2022 7.536M
September 30, 2022 7.647M
June 30, 2022 6.515M
March 31, 2022 6.896M
December 31, 2021 6.485M
September 30, 2021 6.599M
June 30, 2021 5.489M
March 31, 2021 5.236M
December 31, 2020 5.088M
September 30, 2020 -25.91M
June 30, 2020 14.00M
March 31, 2020 15.32M
December 31, 2019 14.40M
September 30, 2019 -24.17M
June 30, 2019 14.24M
March 31, 2019 14.10M
December 31, 2018 13.15M
September 30, 2018 12.14M
June 30, 2018 12.04M
March 31, 2018 11.35M
December 31, 2017 11.40M
Date Value
September 30, 2017 5.727M
June 30, 2017 11.96M
March 31, 2017 11.34M
December 31, 2016 10.84M
September 30, 2016 5.033M
June 30, 2016 12.82M
March 31, 2016 13.11M
December 31, 2015 13.28M
September 30, 2015 13.23M
June 30, 2015 12.83M
March 31, 2015 12.68M
December 31, 2014 13.49M
September 30, 2014 14.11M
June 30, 2014 13.49M
March 31, 2014 12.49M
December 31, 2013 12.55M
September 30, 2013 12.58M
June 30, 2013 11.39M
March 31, 2013 11.33M
December 31, 2012 11.52M
September 30, 2012 8.548M
June 30, 2012 11.69M
March 31, 2012 15.56M
December 31, 2011 11.95M
September 30, 2011 11.48M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

-25.91M
Minimum
Sep 2020
15.32M
Maximum
Mar 2020
5.278M
Average
7.536M
Median
Dec 2022

Research and Development Expense (Quarterly) Benchmarks

Bruker Corp 83.50M
Harvard Bioscience Inc 3.15M
Bionano Genomics Inc 11.70M
Akoya Biosciences Inc 4.67M
Singular Genomics Systems Inc 11.69M